Détail de l'auteur
Auteur L. WIESSING |
Documents disponibles écrits par cet auteur (44)
Périodique
L. WIESSING ; G. LIKATAVICIUS ; D. KLEMPOVA ; D. HEDRICH ; NARDONE A. ; P. GRIFFITHS | 2009ENGLISH : HIV-prevention measures specific to injection drug users (IDUs), such as opioid substitution treatment and needle-and-syringe programs, are not provided in many countries where injection drug use is endemic. We describe the incidence[...]Périodique
M. FRISCHER ; M. HICKMAN ; L. KRAUS ; F. MARIANI ; L. WIESSING | 2001ENGLISH : Aims. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has produced methodological guidelines for national drug prevalence estimation. This paper pilots the methods to estimate prevalence for Great Britain and pro[...]Article : Périodique
Cannabis policies are changing in some countries. This may have consequences that extend beyond cannabis-specific outcomes, such as an impact on the consumption patterns of other substances. Changes in cannabis policies may also influence policy[...]NouveautéDocument texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]Article : Périodique
Problem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess publ[...]Rapport
G. HAY ; N. McKEGANEY ; E. BIRKS ; L. WIESSING ; R. HARTNOLL ; P. Y. BELLO ; C. M. COMISKEY ; D. D'IPPOLITI ; A. DOMINGO-SALVANY ; FREIRE S. ; M. MOREIRA ; NORÉN A. ; PARTANEN P. ; POLITIKOU K. ; SEIDLER D. ; F. SMIT ; TOET J. ; A. UHL ; VIRTANEN A. | Lisbon : EMDCCA | 1997ENGLISH : This report presents the findings from an EMCDDA funded Methodological Pilot Study of Local Level Prevalence Estimates. Following on from a joint EMCDDA / Pompidou Group meeting, comparative pilot studies to improve the prevalence es[...]Article : Périodique
FRANÇAIS: Les indicateurs et les modèles peuvent aider à étudier et à comprendre l'épidémiologie de l'usage de drogues au niveau international ou global. Les indicateurs d'usage de drogues sont généralement fondés sur les données normalement di[...]Périodique
C. ACEIJAS ; S. R. FRIEDMAN ; H. L. COOPER ; L. WIESSING ; G. V. STIMSON ; M. HICKMAN | 2006ENGLISH : OBJECTIVE: To present and update available national and subnational estimates of injecting drug users (IDUs) in developing/transitional countries, and provide indicative estimates of gender and age distribution. METHODS: Literature r[...]Article : Périodique
F. SMIT ; TOET J. ; H. VAN OERS ; L. WIESSING |ENGLISH : Objective : To assess the applicability and validity of the Multiple Indicator Method for combining sparsely available local prevalence estimates of problem drug use into a national estimate. Method : Local estimates of problem drug [...]Article : Périodique
L. KRAUS ; R. AUGUSTIN ; M. FRISCHER ; P. KÜMMLER ; A. UHL ; L. WIESSING |FRANÇAIS : A partir des données des services de traitement et de la police, des données sur la mortalité et le VIH/sida, la prévalence des problèmes liés à l'usage de drogues a été estimée dans les pays de l'Union Européenne et en Norvège. Six[...]Périodique
F. SMIT ; M. VAN LAAR ; L. WIESSING | 2006ENGLISH : Aims: Throughout the European Union efforts are made to obtain national estimates of problem drug use. These estimates are required for policy making. Given the importance of the estimates, much depends on their validity. Here we use[...]Périodique
M. HICKMAN ; C. TAYLOR ; A. CHATTERJEE ; L. DEGENHARDT ; M. FRISCHER ; G. HAY ; K. TILLING ; L. WIESSING ; P. GRIFFITHS ; R. McKETIN | 2002Les décideurs ont de plus en plus besoin d'estimations de la prévalence de la consommation problématique de drogues, comme l'usage par voie intraveineuse et la consommation de "crack". Dans cet article, les auteurs passent en revue les méthodes [...]Article : Périodique
ENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]Périodique
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
B. M. MATHERS ; L. DEGENHARDT ; B. PHILLIPS ; L. WIESSING ; M. HICKMAN ; S. A. STRATHDEE ; A. WODAK ; PANDA S. ; M. TYNDALL ; A. TOUFIK ; R. P. MATTICK | 2008ENGLISH : BACKGROUND: Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among peo[...]Rapport
G. P. SCALIA TOMBA ; C. ROSSI ; C. TAYLOR ; D. KLEMPOVA ; L. WIESSING | Lisbon : OEDT / EMCDDA | Scientific Reports | 2008Monitoring the incidence of problem drug use - the rate at which people who will become problem users start using or injecting drugs for the first time - plays an important part in tracing new trends in Europe’s drug situation and in helping to [...]Rapport
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of ri[...]Périodique
J. REIMER ; B. SCHULTE ; X. CASTELLS ; I. SCHAFER ; POLYWKA S. ; D. HEDRICH ; L. WIESSING ; C. HAASEN ; M. BACKMUND ; M. KRAUSZ | 2005ENGLISH : Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDU[...]Article : Périodique
FRANÇAIS : L'hépatite C est devenue ces dernières années l'une des principales menaces pour la santé publique mondiale. L'Union européenne compterait plus d'un million de porteurs mais, en l'absence de données précises, il est possible que ce [...]Rapport
OEDT = EMCDDA ; M. HICKMAN, Éditeur scientifique ; N. K. MARTIN, Éditeur scientifique ; I. GIRAUDON ; L. WIESSING ; D. HEDRICH ; E. KALAMARA ; P. GRIFFITHS ; R. SIMON | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2016FRANÇAIS : L'hépatite C est une maladie infectieuse du foie causée par le virus de l'hépatite C (VHC) qui peut être transmis par le sang. Environ 115 millions de personnes à travers le monde ont été infectées à un moment donné de leur vie par l[...]Article : Périodique
L. NORDEN ; M. G. VAN VEEN ; C. LIDMAN ; I. TODOROV ; B. GUARITA ; M. KRETZSCHMAR ; L. WIESSING |This study assessed risk behavior and preventive measures for hepatitis C among injecting drug users in Rotterdam, the Netherlands (452 participants, 2002-2003) and Stockholm, Sweden (310 participants, 2004-2006), two cities with contrasting dru[...]Livre
JAGER J. ; LIMBURG W. ; M. KRETZSCHMAR ; POSTMA M. ; L. WIESSING, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2004ENGLISH : Hepatitis C infections occurring in recent years in the European Union may cost countries billions of euros in future healthcare, according to research published in this monograph. A conglomeration of state-of-the-art research on he[...]Article : Périodique
L. WIESSING ; M. FERRI ; B. GRADY ; M. KANTZANOU ; I. SPERLE ; K. J. CULLEN ; EMCDDA DRID Group ; A. HATZAKIS ; M. PRINS ; P. VICKERMAN ; J. V. LAZARUS ; V. D. HOPE ; C. MATHEI |Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of informati[...]Article : Périodique
ENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]Article : Périodique
D. C. DES JARLAIS ; V. SYPSA ; J. FEELEMYER ; A. O. ABAGIU ; V. ARENDT ; D. BROZ ; D. CHEMTOB ; C. SEGUIN-DEVAUX ; J. M. DUWVE ; M. FITZGERALD ; D. J. GOLDBERG ; A. HATZAKIS ; R. E. JIPA ; E. KATCHMAN ; E. KEENAN ; I. KHAN ; S. KONRAD ; A. McAULEY ; S. SKINNER ; L. WIESSING |During 2011-16, HIV outbreaks occurred among people who inject drugs (PWID) in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel Aviv), Luxembourg, Romania (Bucharest), Scotland (Glasgow), and USA (Scott County, [...]Article : Périodique
B. M. MATHERS ; L. DEGENHARDT ; H. ALI ; L. WIESSING ; M. HICKMAN ; R. P. MATTICK ; B. MYERS ; A. AMBEKAR ; S. A. STRATHDEE ; Reference Group to the UN on HIV and Injecting Drug Use |Background: Previous reviews have examined the existence of HIV prevention, treatment, and care services for injecting drug users (IDUs) worldwide, but they did not quantify the scale of coverage. We undertook a systematic review to estimate nat[...]